CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
NCT06238765 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-02-09
Summary
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Conditions
Sponsors & Collaborators
-
CorEvitas
lead NETWORK
Eligibility
- Min Age
- 12 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-12-02
- Primary Completion
- 2099-12-31
- Completion
- 2099-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
NCT07309055 ·Status: RECRUITING ·Phase: PHASE3
-
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
NCT05916365 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
NCT03250624 ·Status: COMPLETED ·Phase: PHASE2
-
CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
NCT05614817 ·Status: WITHDRAWN ·Phase: PHASE3
-
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis
NCT03632174 ·Status: COMPLETED ·Phase: NA
-
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
NCT06174493 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
NCT05579899 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
NCT05669794 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
NCT05139836 ·Status: ACTIVE_NOT_RECRUITING
-
Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
NCT04564755 ·Status: NO_LONGER_AVAILABLE
-
A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment
NCT06192563 ·Status: RECRUITING
-
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
NCT05203380 ·Status: COMPLETED
-
Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT04195698 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
NCT05372419 ·Status: COMPLETED ·Phase: PHASE3
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05999799 ·Status: TERMINATED ·Phase: PHASE2
-
A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)
NCT03921411 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
NCT05029895 ·Status: COMPLETED
-
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
NCT06988605 ·Status: RECRUITING
-
A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis
NCT03920852 ·Status: COMPLETED ·Phase: PHASE1